| R2R Senior Specialist - GL & Reporting |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Окт. 08, 2024 |
| Expert Analyst – Management Reporting |
Prague |
Czech Republic |
Finance |
Corporate |
Audit & Finance |
Окт. 08, 2024 |
| FRA Specialist - Asset Management |
Prague |
Czech Republic |
Finance |
CTS |
Audit & Finance |
Окт. 08, 2024 |
| Global Finance Master Data Sr Specialist |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
Окт. 08, 2024 |
| Site Finance Head |
Morris Plains |
USA |
Finance |
Innovative Medicines |
Audit & Finance |
Окт. 04, 2024 |
| Digital Finance, Data & Tools Analyst |
Barcelona Gran Vía |
Spain |
Finance |
CTS |
Audit & Finance |
Окт. 11, 2024 |
| Financial Reporting & Accounting Specialist |
Baarle Nassau |
Netherlands |
Finance |
Sandoz |
Audit & Finance |
Окт. 11, 2024 |
| Senior Finance Specialist – Digital Analytics and Operations |
Barcelona Gran Vía |
Spain |
Finance |
Innovative Medicines |
Audit & Finance |
Окт. 11, 2024 |
| Tax Specialist |
Mumbai (Head Office) |
India |
Finance |
Corporate |
Audit & Finance |
Окт. 14, 2024 |
| Manager, Digital Finance |
Hyderabad (Office) |
India |
Finance |
Innovative Medicines |
Audit & Finance |
Окт. 09, 2024 |
| Revenue Deduction & Accounting Statutory Lead |
Warsaw |
Poland |
Finance |
CTS |
Audit & Finance |
Окт. 10, 2024 |
| R2R Team Lead - GL & Reporting |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Окт. 10, 2024 |
| Senior Manager - Direct tax |
Mumbai (Head Office) |
India |
Finance |
Corporate |
Audit & Finance |
Окт. 10, 2024 |
| BPA (Budget & Planning Analyst) |
İstanbul Kurtköy |
Turkey |
Finance |
Innovative Medicines |
Audit & Finance |
Окт. 10, 2024 |
| Investor Relations Executive Director |
East Hanover |
USA |
Finance |
Corporate |
Audit & Finance |
Авг. 28, 2024 |
| Senior Accountant, Tax |
Shanghai (Shanghai) |
China |
Finance |
Corporate |
Audit & Finance |
Авг. 29, 2024 |
| R2R Senior Specialist - Inventory |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Окт. 02, 2024 |
| Associate, Record-to-Report |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Finance |
CTS |
Audit & Finance |
Юни 26, 2024 |
| Revenue Accounting Manager |
Shanghai (Shanghai) |
China |
Finance |
CTS |
Audit & Finance |
Юли 17, 2024 |
| (高级)地区经理 |
Bozhou (Anhui Province) |
China |
International |
Innovative Medicines |
Sales |
Септ. 24, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Taiyuan (Shanxi Province) |
China |
International |
Innovative Medicines |
Sales |
Септ. 24, 2024 |
| 县域主任(主管) |
Luoyang (Henan Province) |
China |
International |
Innovative Medicines |
Sales |
Септ. 26, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Xian (Shanxi Province) |
China |
International |
Innovative Medicines |
Sales |
Септ. 29, 2024 |
| Therapy Area Partner |
Abha |
Saudi Arabia |
International |
Innovative Medicines |
Sales |
Окт. 01, 2024 |
| TA Strategy Lead - GenMed |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Окт. 02, 2024 |
| CX strategy |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Окт. 04, 2024 |
| TA Strategy Lead, RLT (Prostate Cancer) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Окт. 07, 2024 |
| Lead, Integrated Insights & Planning_市場調査 |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Окт. 07, 2024 |
| Associate, TA Medical (General Medicines) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
Окт. 07, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Sales |
Окт. 09, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Yibin (Sichuan Province) |
China |
International |
Innovative Medicines |
Sales |
Окт. 09, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Chongqing (Chongqing Province) |
China |
International |
Innovative Medicines |
Sales |
Окт. 09, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Nanjing (Jiangsu Province) |
China |
International |
Innovative Medicines |
Sales |
Окт. 10, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Guiyang (Guizhou Province) |
China |
International |
Innovative Medicines |
Sales |
Окт. 11, 2024 |
| Senior MR |
Shenzhen (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Окт. 14, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Guiyang (Guizhou Province) |
China |
International |
Innovative Medicines |
Sales |
Окт. 14, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Linfen (Shanxi Province) |
China |
International |
Innovative Medicines |
Sales |
Окт. 14, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Kuerle (Xinjiang Province) |
China |
International |
Innovative Medicines |
Sales |
Окт. 16, 2024 |
| MR |
Changsha (Hunan Province) |
China |
International |
Innovative Medicines |
Sales |
Окт. 17, 2024 |
| Business Excellence & Execution IM Head, Mexico |
INSURGENTES |
Mexico |
International |
Innovative Medicines |
Marketing |
Окт. 17, 2024 |
| Senior/Advanced Medical/Sales Representative |
Beijing (Beijing) |
China |
International |
Innovative Medicines |
Sales |
Окт. 17, 2024 |
| 县域主任/县域主管 |
Dazhou (Sichuan Province) |
China |
International |
Innovative Medicines |
Sales |
Юли 04, 2024 |
| Senior District Manager |
Zhanjiang (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Юли 05, 2024 |
| DM |
Fuzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Юли 18, 2024 |
| MR |
Shenzhen (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Юли 22, 2024 |
| Product Specialist |
Fuzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Юли 23, 2024 |
| Medical Science Liaison Neuro |
Ekaterinburg |
Russian Fed. |
International |
Innovative Medicines |
Research & Development |
Юли 25, 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Юли 28, 2024 |
| County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Юли 28, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Юли 30, 2024 |